MATERIAL EVENT4530.TTSE

Hisamitsu Pharmaceutical Co: change in major shareholder

Summary

HISAMITSU PHARMACEUTICAL CO., INC. filed an extraordinary report via EDINET on 2026-04-28 13:17 JST. Reason(s) cited: extraordinary report.

Open the price chart on TradingView.

Source: EDINET S100Y0QK ↗ · PDL1.0 · Not investment advice